Asia Green Biotechnology Corp. (TSE:ASIA)
:ASIA
Top Page
No summary available
Positive Factors
Innovative Product Offering
ASIA's focus on innovative plant-based technologies positions it well in sustainable agriculture, potentially driving long-term demand.
Negative Factors
Severe Financial Distress
The lack of revenue and high operational losses indicate severe financial distress, threatening long-term viability without a turnaround.
Read all positive and negative factors
Positive Factors
Negative Factors
Innovative Product Offering
ASIA's focus on innovative plant-based technologies positions it well in sustainable agriculture, potentially driving long-term demand.
Read all positive factors
Asia Green Biotechnology Corp. (ASIA) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$543.71K
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)0.00
Revenue GrowthN/A
EPS GrowthN/A
CountryCA
EmployeesN/A
SectorGeneral
Sector StrengthN/A
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding36,247,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-0.78
Price to Sales (P/S)0.00
P/FCF Ratio-10.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Asia Green Biotechnology Corp. Business Overview & Revenue Model
Company Description
Asia Green Biotechnology Corp., an early stage international bio-technology company, focuses on the development, evaluation, testing, application, and supply of products derived from proprietary organic hybridization technology in Asia. The compan...
How the Company Makes Money
Asia Green Biotechnology Corp. makes money through the sale of its biotech agricultural products, including genetically modified seeds, biopesticides, and biofertilizers to farmers and agricultural companies. The company also generates revenue by ...
Asia Green Biotechnology Corp. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -317.98K | 23.16K | -179.00K | -523.00K | -553.00K | -687.00K |
| Net Income | -350.29K | -221.00K | -198.00K | -525.00K | -553.00K | -767.00K |
Balance Sheet | ||||||
| Total Assets | 7.36K | 65.34K | 68.18K | 116.30K | 441.38K | 1.05M |
| Cash, Cash Equivalents and Short-Term Investments | 198.00 | 1.31K | 12.40K | 67.27K | 381.15K | 1.02M |
| Total Debt | 237.41K | 237.41K | 190.70K | 150.00K | 0.00 | 0.00 |
| Total Liabilities | 666.63K | 527.31K | 308.98K | 193.09K | 28.33K | 88.95K |
| Stockholders Equity | -659.27K | -461.98K | -240.80K | -76.79K | 413.05K | 965.88K |
Cash Flow | ||||||
| Free Cash Flow | -2.25K | -36.09K | -125.35K | -463.88K | -640.78K | -670.67K |
| Operating Cash Flow | -2.25K | -36.09K | -125.35K | -463.88K | -640.78K | -670.67K |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | 25.00K | 70.48K | 150.00K | 0.00 | 1.21M |
Asia Green Biotechnology Corp. Peers Comparison
UnderperformOutperform
Sector (55)
TSE:ASIA
Asia Green Biotechnology Corp.
0.02
0.00
0.00%
TSE:VIBE
Vibe Bioscience Ltd
0.04
-0.02
-30.00%
TSE:GHG
Global Hemp
0.02
0.00
0.00%
TSE:CNTR
CENTR Brands
0.04
-0.01
-20.00%
TSE:XBRA
Xebra Brands Ltd.
0.01
-0.07
-87.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―